Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Operating Expenses | 5,980 | 5,847 | 4,271 | 4,936 | 1,632 |
| Operating Income | -5,980 | -5,847 | -4,271 | -4,936 | -1,632 |
| Interest Expense | 33 | 0 | 0 | 1 | 1 |
| Other Income | 1,454 | 96 | 385 | 11,753 | -187 |
| Pre-tax Income | -4,559 | -5,752 | -3,886 | 6,817 | -1,820 |
| Net Income Continuous | -4,178 | -5,752 | -3,886 | 6,817 | -1,820 |
| Net Income | $-4,178 | $-5,752 | $-3,886 | $6,817 | $-1,820 |
| EPS Basic Total Ops | -1.41 | -1.10 | -0.75 | 1.82 | -0.53 |
| EPS Basic Continuous Ops | -1.41 | -1.10 | -0.75 | 1.82 | -0.53 |
| EPS Diluted Total Ops | -1.06 | -1.10 | -0.75 | 1.47 | -0.53 |
| EPS Diluted Continuous Ops | -1.06 | -1.10 | -0.75 | 1.47 | -0.53 |
| EBITDA(a) | $-5,976 | $-5,816 | $-4,227 | $-4,917 | $-1,584 |